Award
National Cancer Institute 5R01CA293188-03
Discovery of small molecules targeting Polycomb repressive complexes 1 and 2
Recipient
National Cancer Institute (NCI), part of the NIH
Award Amount
$451,485.00
Ceiling
$451,485.00
Awarded
July 16, 2026
Identifier
5R01CA293188-03
Award for research to discover small molecules targeting Polycomb repressive complexes for cancer therapy, managed by the National Cancer Institute with a budget of $451,485.
Description
The project aims to identify small molecules that inhibit Polycomb Repressive Complexes 1 and 2. The award is managed by the National Cancer Institute, part of NIH. The project involves developing assays and screening compounds for therapeutic development in cancer treatment. The project duration is from August 1, 2024, to July 31, 2027. The project is part of a multi-year effort with a total budget of approximately $451,485. The project focuses on epigenetic targets related to chromatin regulation in cancer.